Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, Keith A.A. Fox et autres
319 citationsThe Lancet